You are browsing the Hong Kong website, Regulated by Hong Kong SFC (CE number: BJA907). Investment is risky and you must be cautious when entering the market.
藍帆醫療(002382.SZ):“第三期年產25億支健康防護(新型手套)項目”生產線建成投產
格隆匯 09-21 16:52

格隆匯 9 月 21日丨藍帆醫療(002382.SZ)公佈,2020年,全球範圍內爆發新型冠狀病毒肺炎疫情,在疫情抗擊過程中丁腈手套發揮了重要的作用,受此影響,世界各國對丁腈手套等各類醫療防護用品的需求暴增,產品供不應求,帶來市場價格大幅上漲,產能極度緊張。同時,丁腈手套因其優異的防護性、拉伸強度、貼手舒適性和廣泛的應用領域等特性,顯現出長遠的發展潛力,成為近年來醫療及防護手套各品類中增速最快的高端品種,因此公司將丁腈手套項目建設作為重點發展方向。基於此,公司於2020年2月提前啟動了“第三期年產20億支健康防護(新型手套)項目(實際產能可以達到25億支)”,目前生產線建設已完工,開始試生產,並於2020年9月20日順利產出合格的丁腈手套產品,實現一次開車成功。後續公司將進一步優化相關工藝參數,完善生產現場管理,提高裝備生產運行水平。

“第三期年產25億支健康防護(新型手套)項目”的投產,對於為緩解極度緊張的產能增添了部分助力,可以充分發揮公司的核心競爭優勢,進一步提高公司醫療及防護手套的產能,增強公司行業競爭能力和盈利能力;同時,對於豐富公司產品線,實現更為合理的銷售佈局起到積極的推進作用。

鑑於國外疫情對醫療及健康防護手套需求的持續增加,產能持續緊張,公司“年產20億支TPE手套項目建設工作”正在全力推進中,預計將於近期投產,滿足下游客户對防護產品的多樣化、綜合化的一站式採購需求。同時,300億支/年健康防護(丁腈)手套項目一期已經在籌備過程中,後續開工建設及產能的釋放能更好地滿足市場需求,緩解供不應求的緊張局面,上述項目的投產將有效支撐產能的釋放和客户需求,進一步夯實國際市場份額,有利於保障公司未來年度業績增長,對公司後續發展有積極影響。

Follow us
Find us on Facebook, Twitter , Instagram, and YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!
Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.
uSMART
Wealth Growth Made Easy
Open Account